Chronic musculoskeletal pain affects more than one in five adults, contributes more to global disability than any other condition category, and costs the United States over $600 billion annually in healthcare expenditure and lost productivity.¹ Those numbers are not a reflection of how difficult chronic pain is to treat. They are a reflection of how consistently it is treated the wrong way.
Research consistently shows that patients who access non-pharmacological care — acupuncture, physical therapy, chiropractic — as their first point of contact for musculoskeletal pain are significantly less likely to be prescribed opioids than those who enter the system through other pathways.² The sequence of care matters. Who you see first, and in what order, shapes the trajectory of your pain more than most patients — or providers — realize.
This post is about three specific ways that trajectory falls short, and what a progression that actually holds looks like.
The Diagnosis Disconnect
The first failure point is often the one that feels most like progress: getting a diagnosis.
Imaging — X-ray, MRI, CT — has become the standard first response to chronic musculoskeletal pain, particularly in the spine. For acute trauma, this makes clinical sense. For chronic pain that has been present for months or years, the picture is considerably more complicated.
The incidental findings problem
In 2015, Brinjikji and colleagues published a systematic review in the American Journal of Neuroradiology examining imaging findings in completely asymptomatic individuals — people with no pain.³ The results were striking. Disc degeneration was present in 37% of asymptomatic 20-year-olds, rising to 96% by age 80. Disc bulges appeared in 30% of 20-year-olds and 84% of 80-year-olds. Disc protrusions, annular fissures, and facet degeneration showed similar age-related prevalence — entirely independent of pain.
The implication is significant: many of the findings that appear on a chronic pain patient’s MRI are not pathological. They are normal features of an aging musculoskeletal system, present in equal measure in people who feel fine. The finding on the image is not necessarily the explanation for the pain.
This does not mean imaging is without clinical value. It means that a structural finding requires careful interpretation before it becomes the organizing principle of a treatment plan.
The communication problem
The second issue is subtler and arguably more consequential. It is not just that imaging finds things — it is that being told about those findings changes outcomes, independent of what the findings actually are. A 2021 randomized controlled trial published in the European Spine Journal tested this directly. Patients who received a factual explanation of their MRI report showed more negative perception of their spinal condition, increased catastrophization, decreased pain improvement, and poorer functional status compared to those who were reassured that findings represented normal changes. The same study found that standard MRI reporting language shifted healthcare providers toward more severe disease assessment and greater likelihood of recommending surgical intervention — across four categories of providers, blinded to each other’s assessments.⁴
What emerges is a cycle. Imaging identifies a structural feature. The patient receives a label. Movement behavior changes in response to that label. The label becomes an identity. And treatment proceeds against the backdrop of a prognosis shaped as much by communication as by pathology.
A patient who leaves an appointment knowing they are “a herniated disc person” is clinically different from one with identical imaging findings who has been told those findings are common, frequently asymptomatic, and not the complete picture. The difference is not in the spine. It is in how the nervous system interprets what the spine means.
When Active Care Backfires
Most patients who arrive with chronic musculoskeletal pain have already been through treatment. Physical therapy, chiropractic, massage — often in combinations and sequences they’ve lost track of. What brings them in is not a lack of trying. It’s that the trying didn’t hold.
Understanding why requires distinguishing between two clinical variables that are frequently collapsed into one: symptom threshold and load capacity.
Two different problems, two different tools
Passive therapy — needling, manual therapy, bodywork — works primarily by raising the threshold at which symptoms present. A system that was provoked by thirty minutes of walking begins to tolerate an hour. The nervous system’s threat response becomes less reactive to the same inputs. This is not resolution of the underlying problem. It is the creation of a window — a reduction in reactivity that makes the next stage of work possible.
Active therapy — progressive exercise, corrective movement, functional rehabilitation — works by increasing overall load capacity. The tissues, stabilizing structures, and neuromuscular patterns that support movement become better at handling demand. This is where lasting change is built.
These are not competing approaches. They are sequential ones. The problem arises when they are applied in the wrong order — or without understanding which phase the patient is actually in.
The irritability problem
Chronic musculoskeletal pain that has persisted for months or years is frequently accompanied by high clinical irritability — a state in which symptoms are provoked easily and take a disproportionately long time to settle once triggered.⁵ This is not simply a measure of pain severity. It reflects a nervous system that has undergone central sensitization: a process by which repeated nociceptive input progressively lowers pain thresholds and increases the gain on pain signaling throughout the central nervous system.⁶
In a highly irritable system, progressive loading does not build capacity. It provokes symptoms, reinforces the nervous system’s threat assessment, and confirms the patient’s developing belief that movement is dangerous. The intervention becomes evidence against recovery.
This is the mechanism behind what patients describe when they say physical therapy made things worse. In most cases, the therapy was not the problem. The threshold was too low to tolerate it productively at the time it was applied.
The residue of a failed attempt
A patient who has failed active care is not the same clinical presentation as one who has never tried it. The physical picture — an irritable, sensitized system — may be similar. But layered over it is a psychological residue with direct clinical consequences.⁷ Fear-avoidance — the tendency to interpret movement as threat and avoid it accordingly — is well-documented in chronic pain populations and is significantly amplified by negative treatment experiences.⁸ A patient pushed into progressive rehabilitation before their threshold could support it, who experienced a flare and concluded that exercise is harmful, is now carrying that conclusion into every subsequent clinical encounter. The door to active rehabilitation has not just failed to open. It has been actively pushed shut.
Reopening it requires an honest explanation of what happened — not as a failure of the patient or necessarily of the prior provider, but as a sequencing problem. Here is what was likely happening in your body when you tried that. Here is why the experience was what it was. Here is what is different now and why the outcome would likely be different.
Function and mobility goals as the clinical framework
Before treatment begins, establishing specific function and mobility goals does two things simultaneously. For the patient, it reorients care away from pain reduction as the primary metric toward the recovery of meaningful capacity — what they cannot currently do that they want to do. For the clinician, it provides the framework for physical examination and a concrete measure against which progress can be evaluated at every checkpoint.
A goal of returning to a thirty-minute walk, getting back on a bike, or lifting without consequence the following day is not merely motivating. It is diagnostic. Examination findings — range of motion, movement quality, load tolerance, compensatory patterns — all map against a specific functional and mobility target rather than a generalized pain scale.
This matters at every assessment point. The question at the two-week mark is not “is your pain better.” It is “how does your body respond to the activities that matter to you between sessions.” Lifestyle response — what the patient can do in the context of their actual life, not in the treatment room — is the most clinically relevant indicator of whether passive work is raising the threshold enough to introduce progressive loading.
The transition is a blend, not a handoff
When threshold response supports it, active work enters the program — but not as a replacement for passive care. The ratio shifts gradually. Passive modalities continue alongside early active work, managing the irritability response as load increases and providing a buffer as the system builds its capacity to hold the gains independently.
When Relief Replaces Progress
Passive care is not the problem. Used appropriately — at the right phase, with a defined clinical role, and within a broader progression plan — it is an essential component of chronic pain treatment. The problem is passive care without a defined endpoint, without functional goals anchoring the work, and without an honest conversation when progress plateaus.
That combination is more common than it should be, and it produces a predictable outcome: treatment continues, the patient returns, and neither party has a clear sense of whether anything is still moving.
Why the model produces the pattern
Fee-for-service practice does not reward graduation. There is no structural incentive built into most care models to move patients through and out. A provider who discharges a patient who is no longer progressing loses a visit. A provider who continues treatment loses nothing — and may genuinely believe they are helping, because passive care often does provide relief, even when it is no longer producing progress.
This is not a character indictment of individual practitioners. It is a predictable output of a payment model that measures care in appointments rather than outcomes. When the structure does not require an honest assessment of whether treatment is still advancing, that assessment tends not to happen — not because providers are indifferent to their patients, but because the system does not build it in.
Why patients stay
Patient behavior in this dynamic is equally understandable. Chronic pain is exhausting. If treatment reliably provides two days of relief, and nothing else in a patient’s life does, returning for that relief is rational — even if the underlying condition is not improving. The treatment has shifted from a bridge to a crutch without either party formally acknowledging the transition.
This is not a patient failure. It is what happens when care is organized around relief rather than recovery, and when no one has established what graduation looks like or when the conversation about it should happen.
The distinction that matters
There is a meaningful clinical difference between intentional ongoing care and care that is simply continuing.
Intentional ongoing care is a deliberate clinical decision — appropriate for certain presentations where the goal is management rather than resolution, where condition complexity or patient capacity genuinely limits the pace of active progression, and where that decision has been made explicitly and revisited regularly. Some patients benefit from ongoing passive support as a legitimate part of their long-term plan. That is a clinical choice, not a default.
Care that is simply continuing is something different. It is treatment that began with a goal and gradually lost it — where progress has plateaued, where the functional and mobility targets established at intake are no longer being meaningfully approached, and where the honest conversation about next steps has been deferred indefinitely.
The difference between them is not always visible from the outside. It lives in whether the provider can answer a simple question: what is this patient working toward, and is treatment still moving them there?
What the plateau signal means
In practice, the pattern often announces itself through a consistent plateau. The patient is managing — pain is tolerable, function is adequate — but the needle has not moved in weeks or months. Sessions feel maintenance-like rather than progressive. The treatment has become a habit rather than a plan.
This is a clinical signal, not a treatment failure. A plateau means the current intervention has reached the ceiling of what it can produce alone. The appropriate response is an honest evaluation: what does the patient still want to get back, where are they relative to that goal, and what does the next stage of care look like — whether that continues here, transitions to more active rehabilitation, or involves a different provider entirely.
That conversation, held honestly and held early, is what separates a treatment program from an indefinite care relationship.
Building a Progression That Holds
Everything in the preceding sections points toward the same underlying principle: chronic musculoskeletal pain treatment falls short not because the tools are wrong, but because the sequencing is. The right approach addresses all three failure modes simultaneously — it interprets imaging findings in clinical context rather than letting them define the patient, it respects the threshold before introducing load, and it builds a defined progression toward graduation rather than an open-ended care relationship.
Here is what that looks like in practice.
The early phase: establishing a response
Treatment begins with a clear clinical question: does this patient’s system respond to passive intervention in a meaningful way? This is not assumed. It is tested.
In the early sessions, post-treatment soreness is normal and should be expected. A nervous system that has been in a sustained threat state, and tissue that has been guarded and reactive for months or years, responds to intervention. That response can feel like a temporary increase in symptoms in the twenty-four to forty-eight hours following a session. It is not a sign that treatment caused harm. It is the body processing change.
Understanding this distinction matters enormously at this stage. A patient who interprets normal post-treatment soreness as evidence that treatment made them worse will stop — and the clinical opportunity closes before it has had a chance to open. Framing the expected response honestly at the outset is not just good patient communication. It is a clinical intervention in its own right.
Within the first few sessions, most patients begin to notice something beyond the soreness: a window of time following treatment where pain is meaningfully reduced, movement feels different, or activities that were consistently provocative become temporarily more accessible. That window is the first clinical signal. It tells us the threshold is moveable — that the nervous system is capable of downregulating its threat response in response to treatment. Without it, the clinical conversation changes. With it, the goal becomes extending it.
Mid-treatment: extending the window
As treatment progresses, the window grows. A patient who initially noticed one day of meaningful relief begins to experience two or three. The passive work — needling as the primary tool, supported by manual therapy where appropriate — continues to raise the threshold incrementally.
The measure of progress at this stage is not what happens in the treatment room. It is what happens in the patient’s life between sessions. Are the activities that define their functional and mobility goals becoming more accessible? Is the cost of daily movement — the pain that follows a walk, a work shift, an hour in the garden — decreasing? Lifestyle response between sessions is the most clinically relevant data available at this stage, and it is the primary indicator used at each checkpoint evaluation.
This is where the function and mobility goals established at intake earn their value. A patient whose goal is to return to cycling has a concrete, observable measure of progress that a pain scale cannot capture. The physical examination at each checkpoint maps directly against that target — range of motion, load tolerance, movement quality — giving both provider and patient a shared and honest picture of where things stand.
Flares can occur during this phase, particularly following sessions where more tissue is addressed or technique is adjusted. The clinical distinction is important: a flare that settles within forty-eight to seventy-two hours and leaves the patient at or above their prior baseline is a normal treatment response. One that persists beyond that window, or that drops the patient meaningfully below where they were, is a signal to reassess. Managing that distinction — and communicating it clearly to the patient — is part of what keeps the progression on track rather than derailing it.
The movement entry point
As the window of relief extends toward a week or more of sustained improvement, active work enters the program. The timing is deliberate. A system that has demonstrated the capacity to maintain several days of meaningful relief between sessions has also demonstrated the capacity to tolerate progressive loading without the same risk of provoking a setback that characterized the earlier phase.
Movement is introduced gradually — corrective exercise, functional stability work, and patient-directed home practice that increases in demand as the system demonstrates it can hold the gains. The passive work does not stop at this point. It continues alongside active rehabilitation, managing the irritability response as load increases and providing a buffer during the natural fluctuations that are part of any progressive program. This overlap is not incidental — it is a deliberate flare management strategy, maintaining the threshold work while load capacity is being built.
Flares during this phase are more common than in the passive phase and should be anticipated rather than feared. Introducing progressive load into a system that has been sensitized for months or years will occasionally provoke a temporary increase in symptoms. Over time, as load capacity increases and the system becomes more resilient, these responses become shorter in duration and milder in intensity. The trajectory is not a smooth line upward. It is a trend — one that, when it is moving in the right direction, accommodates fluctuation without losing ground.
The ratio of passive to active work shifts over time. As load capacity increases and the system becomes more resilient, dependence on passive care decreases — not because a decision was made to stop it, but because the need for it diminishes as the patient’s body becomes better at managing its own demands.
Checkpoints and honest evaluation
Built into this progression are defined evaluation points — moments where provider and patient step back from the work and ask honestly: where are we relative to where we started, and where we said we wanted to go?
These evaluations require distinguishing between two different clinical pictures that can look superficially similar. A flare — a temporary increase in symptoms during an otherwise progressing course of treatment — is not the same as a plateau. A plateau is a consistent absence of forward movement toward functional and mobility goals across multiple sessions, with no clear precipitating cause and no recovery back to prior gains. One is part of a healthy progression. The other is a signal that the current approach has reached its ceiling.
When a genuine plateau is identified, the next stage of care needs to be determined honestly. Sometimes that means an adjustment within the current program. Sometimes it means referral to more advanced rehabilitation, to a provider better suited to the patient’s next phase of need. When referral is the right call, the transition is managed deliberately — with an overlap period where both approaches run in parallel until the patient is established and the handoff is complete.
The referral conversation, when it is needed, is framed honestly: here is what we have accomplished, here is where the data tells us you need to go next, and here is who I trust to take you there. That is not a failure of treatment. It is treatment working exactly as it should.
Chronic pain has a way of making people feel like the problem is them — that they haven’t tried hard enough, haven’t found the right thing, or aren’t the kind of person who gets better. That narrative is almost always wrong.
The more common story is a system that applied the right tools in the wrong order, or kept applying them past the point where they were still moving anything. That is a planning problem, not a patient problem. And it is a solvable one.
If you’ve been through treatment that didn’t hold — or haven’t found a starting point that feels honest — a free 15-minute call is the place to begin. No pitch, no pressure. Just an honest conversation about what you’re dealing with and whether this is the right fit.
References
¹ Global burden/cost of musculoskeletal pain — Gaskin DJ, Richard P. “The economic costs of pain in the United States.” J Pain. 2012;13(8):715-724. Verify current figures against Global Burden of Disease Study 2019 data.
² Blanchette MA et al. Association of Initial Provider Type on Opioid Fills for Individuals With Neck Pain. Arch Phys Med Rehabil. 2020. (427,966 patient retrospective analysis — verify full citation before publishing.) *
³ Brinjikji W, Luetmer PH, Comstock B, et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol. 2015;36(4):811-816.
⁴ Rajasekaran S, Dilip Chand Raja S, Pushpa BT, et al. The catastrophization effects of an MRI report on the patient and surgeon and the benefits of ‘clinical reporting’: results from an RCT and blinded trials. Eur Spine J. 2021;30(7):2069-2081. doi:10.1007/s00586-021-06809-0
⁵ Maitland GD. Vertebral Manipulation. 5th ed. Butterworth-Heinemann; 1986. (Classical irritability grading framework — verify with contemporary pain sensitization literature.)
⁶ Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2-15.
⁷ Darlow B, Dowell A, Baxter GD, et al. The enduring impact of what clinicians say to people with low back pain. Ann Fam Med. 2013;11(6):527-534.
⁸ Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000;85(3):317-332.